Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6700
+0.0300 (1.83%)
NASDAQ · Last Trade: Feb 16th, 11:59 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors